Table 1.
Clinical, pathologic, and body composition parameters of the included patients
| Variable | All patients (n = 447) n (%) | OG cancer n (%) | CR cancer n (%) | p valuea |
|---|---|---|---|---|
| Age (years) | ||||
| ≤65 | 133 (30) | 46 (43) | 87 (26) | <0.001 |
| 65–74 | 148 (33) | 40 (37) | 108 (32) | |
| ≥75 | 166 (37) | 22 (20) | 144 (42) | |
| Sex | ||||
| Female | 191 (43) | 33 (31) | 158 (47) | 0.003 |
| Male | 256 (57) | 74 (69) | 181 (53) | |
| Neoadjuvant therapy | ||||
| No | 316 (71) | 43 (40) | 273 (81) | <0.001 |
| Yes | 131 (29) | 65 (60) | 66 (19) | |
| Adjuvant therapy | ||||
| No | 343 (77) | 66 (61) | 277 (82) | <0.001 |
| Yes | 104 (23) | 42 (39) | 62 (18) | |
| TNM stage | ||||
| 1 | 88 (20) | 30 (28) | 58 (17) | 0.052 |
| 2 | 196 (44) | 43 (40) | 153 (45) | |
| 3 | 163 (36) | 35 (32) | 128 (38) | |
| Lymphovascular invasion | ||||
| Yes | 111 (25) | 51 (47) | 60 (18) | <0.001 |
| No | 336 (75) | 57 (53) | 279 (82) | |
| Anemiab,c | ||||
| Yes | 186 (42) | 44 (42) | 142 (42) | 0.873 |
| No | 255 (58) | 62 (58) | 193 (58) | |
| White cell count (× 109/L)c | ||||
| <8.5 | 280 (63) | 70 (66) | 210 (63) | 0.711 |
| 8.5–11 | 109 (25) | 23 (22) | 86 (26) | |
| >11 | 52 (12) | 13 (12) | 39 (12) | |
| Neutrophil count (× 109/L)c | ||||
| <7.5 | 362 (82) | 87 (82) | 275 (82) | 0.997 |
| ≥7.5 | 79 (18) | 19 (18) | 60 (18) | |
| Lymphocyte count (× 109/L)c | ||||
| <1.0 | 94 (21) | 18 (17) | 76 (23) | 0.211 |
| ≥1.0 | 347 (79) | 88 (83) | 259 (77) | |
| Albumin (g/L)c | ||||
| ≥35 | 387 (88) | 89 (84) | 298 (89) | 0.172 |
| <35 | 54 (12) | 17 (16) | 37 (11) | |
| Subcutaneous fat index (cm2/m2) | ||||
| Median | 66.2 | 64.9 | 70.0 | 0.114 |
| Range | 200.5 | 193.4 | 191.9 | |
| Low d | 152 (34) | 38 (35) | 114 (34) | |
| Mediumd | 148 (33) | 33 (31) | 115 (34) | |
| Highd | 147 (33) | 37 (34) | 110 (32) | |
| Visceral fat index (cm2/m2) | ||||
| Median | 61.3 | 63.4 | 61.0 | 0.886 |
| Range | 198.4 | 155.0 | 198.4 | |
| Lowe | 152 (34) | 38 (35) | 114 (34) | |
| Mediume | 146 (33) | 38 (35) | 108 (32) | |
| Highd | 149 (33) | 32 (30) | 117 (35) | |
| Skeletal muscle index (cm2/m2) | ||||
| Median | 47.4 | 47.7 | 47.3 | 0.888 |
| Range | 80.1 | 44.2 | 80.1 | |
| Sarcopeniaf | 104 (23) | 23 (21) | 81 (24) | |
| Normal | 343 (77) | 85 (79) | 258 (76) | |
OG esophagogastric, CR colorectal, TNM tumor-node-metastasis
a p Values represent X 2 tests for a linear trend in categorical variables and Mann–Whitney U tests for continuous variables
bAnemia is defined as <13 g/dL in males, <11.5 g/dL in females
cData are missing in six cases
dSex-specific tertiles for subcutaneous fat index
eSex-specific tertiles for visceral fat index
fSarcopenia is defined as <43 cm2/m2 in males and <41 cm2/m2 in females